The global nucleic acid based gene therapeutics market is expected to grow at a CAGR of 12.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic diseases, rising demand for personalized medicine and technological advancements in the field of gene therapy. The DNA segment accounted for the largest share in the global nucleic acid based gene therapeutics market in 2018 and is expected to continue its dominance throughout the forecast period. The RNA segment is projected to grow at a higher CAGR than DNA segment during the forecast period due to its lower cost and ease of production compared with DNA-based therapies. Academic and government research institutes are estimated to account for a significant share in this market owing to their extensive research activities on nucleic acid-based therapies across various therapeutic areas such as cancer, cardiovascular diseases, infectious diseases etc, which will lead them towards developing new drugs that can be used for treatment purposes.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is driving the growth of the global Nucleic-Acid Based Gene Therapeutics market.
- Increasing government funding for research and development in this field is also driving the growth of the global Nucleic-Acid Based Gene Therapeutics market.
- The increasing number of mergers and acquisitions in this field is also driving the growth of the global Nucleic-Acid Based Gene Therapeutics market.
- The increasing number of collaborations between pharmaceutical companies and biotechnology companies in this field is also driving the growth of the global Nucleic-Acid Based Gene Therapeutics market.
Industry Growth Insights published a new data on “Nucleic-Acid Based Gene Therapeutics Market”. The research report is titled “Nucleic-Acid Based Gene Therapeutics Market research by Types (DNA, RNA), By Applications (Academic and Government Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Hospitals and Diagnostic Centers, Others), By Players/Companies Wave Life Sciences, Phylogica, Benitec Biopharma, Celsion, Copernicus Therapeutics, ...”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nucleic-Acid Based Gene Therapeutics Market Research Report
By Type
DNA, RNA
By Application
Academic and Government Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Hospitals and Diagnostic Centers, Others
By Companies
Wave Life Sciences, Phylogica, Benitec Biopharma, Celsion, Copernicus Therapeutics, ...
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Nucleic-Acid Based Gene Therapeutics Market Report Segments:
The global Nucleic-Acid Based Gene Therapeutics market is segmented on the basis of:
Types
DNA, RNA
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic and Government Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Hospitals and Diagnostic Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Wave Life Sciences
- Phylogica
- Benitec Biopharma
- Celsion
- Copernicus Therapeutics
- ...
Highlights of The Nucleic-Acid Based Gene Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DNA
- RNA
- By Application:
- Academic and Government Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Hospitals and Diagnostic Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nucleic-Acid Based Gene Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nucleic-acid based gene therapies are treatments that use nucleic acids, such as DNA or RNA, to treat diseases. These treatments work by correcting the genetic errors that cause the disease.
Some of the major players in the nucleic-acid based gene therapeutics market are Wave Life Sciences, Phylogica, Benitec Biopharma, Celsion, Copernicus Therapeutics.
The nucleic-acid based gene therapeutics market is expected to register a CAGR of 12.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nucleic-Acid Based Gene Therapeutics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Nucleic-Acid Based Gene Therapeutics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Nucleic-Acid Based Gene Therapeutics Market - Supply Chain
4.5. Global Nucleic-Acid Based Gene Therapeutics Market Forecast
4.5.1. Nucleic-Acid Based Gene Therapeutics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Nucleic-Acid Based Gene Therapeutics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Nucleic-Acid Based Gene Therapeutics Market Absolute $ Opportunity
5. Global Nucleic-Acid Based Gene Therapeutics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Nucleic-Acid Based Gene Therapeutics Market Size and Volume Forecast by Type
5.3.1. DNA
5.3.2. RNA
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Nucleic-Acid Based Gene Therapeutics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Nucleic-Acid Based Gene Therapeutics Market Size and Volume Forecast by Application
6.3.1. Academic and Government Research Institutes
6.3.2. Pharmaceutical and Biotechnology Companies
6.3.3. Contract Research Organizations
6.3.4. Hospitals and Diagnostic Centers
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Nucleic-Acid Based Gene Therapeutics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Nucleic-Acid Based Gene Therapeutics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Nucleic-Acid Based Gene Therapeutics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Nucleic-Acid Based Gene Therapeutics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Nucleic-Acid Based Gene Therapeutics Demand Share Forecast, 2019-2029
9. North America Nucleic-Acid Based Gene Therapeutics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Nucleic-Acid Based Gene Therapeutics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Nucleic-Acid Based Gene Therapeutics Market Size and Volume Forecast by Application
9.4.1. Academic and Government Research Institutes
9.4.2. Pharmaceutical and Biotechnology Companies
9.4.3. Contract Research Organizations
9.4.4. Hospitals and Diagnostic Centers
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Nucleic-Acid Based Gene Therapeutics Market Size and Volume Forecast by Type
9.7.1. DNA
9.7.2. RNA
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Nucleic-Acid Based Gene Therapeutics Demand Share Forecast, 2019-2029
10. Latin America Nucleic-Acid Based Gene Therapeutics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Nucleic-Acid Based Gene Therapeutics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Nucleic-Acid Based Gene Therapeutics Market Size and Volume Forecast by Application
10.4.1. Academic and Government Research Institutes
10.4.2. Pharmaceutical and Biotechnology Companies
10.4.3. Contract Research Organizations
10.4.4. Hospitals and Diagnostic Centers
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Nucleic-Acid Based Gene Therapeutics Market Size and Volume Forecast by Type
10.7.1. DNA
10.7.2. RNA
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Nucleic-Acid Based Gene Therapeutics Demand Share Forecast, 2019-2029
11. Europe Nucleic-Acid Based Gene Therapeutics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Nucleic-Acid Based Gene Therapeutics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Nucleic-Acid Based Gene Therapeutics Market Size and Volume Forecast by Application
11.4.1. Academic and Government Research Institutes
11.4.2. Pharmaceutical and Biotechnology Companies
11.4.3. Contract Research Organizations
11.4.4. Hospitals and Diagnostic Centers
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Pojections by Application
11.7. Europe Nucleic-Acid Based Gene Therapeutics Market Size and Volume Forecast by Type
11.7.1. DNA
11.7.2. RNA
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Nucleic-Acid Based Gene Therapeutics Demand Share, 2019-2029
12. Asia Pacific Nucleic-Acid Based Gene Therapeutics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Nucleic-Acid Based Gene Therapeutics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Nucleic-Acid Based Gene Therapeutics Market Size and Volume Forecast by Application
12.4.1. Academic and Government Research Institutes
12.4.2. Pharmaceutical and Biotechnology Companies
12.4.3. Contract Research Organizations
12.4.4. Hospitals and Diagnostic Centers
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Nucleic-Acid Based Gene Therapeutics Market Size and Volume Forecast by Type
12.7.1. DNA
12.7.2. RNA
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Nucleic-Acid Based Gene Therapeutics Demand Share, 2019-2029
13. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size and Volume Forecast by Application
13.4.1. Academic and Government Research Institutes
13.4.2. Pharmaceutical and Biotechnology Companies
13.4.3. Contract Research Organizations
13.4.4. Hospitals and Diagnostic Centers
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Market Size and Volume Forecast by Type
13.7.1. DNA
13.7.2. RNA
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Nucleic-Acid Based Gene Therapeutics Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Nucleic-Acid Based Gene Therapeutics Market: Market Share Analysis
14.2. Nucleic-Acid Based Gene Therapeutics Distributors and Customers
14.3. Nucleic-Acid Based Gene Therapeutics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Wave Life Sciences
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Phylogica
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Benitec Biopharma
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Celsion
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Copernicus Therapeutics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. ...
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook